IMPEDIMED LIMITED — Capital/Financing Update 2012

May 2, 2012

==> picture [96 x 86] intentionally omitted <==

3 May 2012

The Manager Company Announcements Office ASX Limited

IMPEDIMED LIMITED NOTICE UNDER SECTION 708AA(2)(f) CORPORATIONS ACT 2001 (CTH)

ImpediMed Limited ABN 65 089 705 144 ( ImpediMed or the Company ) has announced a pro-rata accelerated non-renounceable entitlement offer of 1 fully paid ordinary share ( New Shares ) for every 4 ImpediMed ordinary shares held as at 7.00 pm (Sydney time) on the record date of 4 May 2012 by shareholders with registered addresses in Australia and New Zealand. This notice is given to ASX under paragraph 708AA(2)(f) Corporations Act 2001 ( Corporations Act ) as modified by Australian Securities & Investments Commission class order CO 08/35.

• 1 ImpediMed will offer the New Shares for issue without disclosure to investors under Part 6D.2 of the Corporations Act.

• 2 As at the date of this notice ImpediMed has complied with the provisions of:

  • (a) Chapter 2M of the Corporations Act as they apply to ImpediMed; and

  • (b) section 674 of the Corporations Act.

• 3 As at the date of this notice there is no excluded information within the meaning of sections 708AA(8) and 708AA(9) of the Corporations Act which is required to be disclosed by ImpediMed.

• 4 The potential effect the issue of the New Shares ( Issue ) will have on the control of ImpediMed and the consequences of that effect are as follows:

  • (a) if all eligible shareholders take up their entitlements under the Entitlement Offer, the Issue will have no significant effect on the control of the Company;

  • (b) if eligible shareholders do not take up all of their entitlements under the Entitlement Offer, the shareholding interests of those eligible shareholders will be diluted;

Unit 1, 50 Parker Court, Pinkenba, QLD 4008 Australia • Tel +61 (7) 3860-3700 Fax +61 (7) 3260-1225 www.impedimed.com

IPD Company Announcement 3 May 2012

• (c) the proportional interests of shareholders with registered addresses outside Australia and New Zealand may be diluted because those shareholders are not entitled to participate in the Entitlement Offer; and

• (d) The Company’s largest shareholder, a fund managed by Allan Gray Australia, (formerly Orbis Investment Management Australia), has committed to the Entitlement Offer and will continue to hold approximately 19.9% of the Company’s issued shares post completion of the Entitlement Offer.

Signed for ImpediMed Limited by

==> picture [108 x 48] intentionally omitted <==

Steve Denaro Company Secretary

2